v3.26.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Oct. 03, 2026
Sep. 27, 2025
Sep. 28, 2024
Cash Flows From Operating Activities:      
Net earnings $ 29,547 $ 41,020 $ 19,305
Adjustments to reconcile net earnings to net cash provided by operating activities:      
Depreciation and amortization 17,735 18,390 15,413
Amortization of capitalized financing costs 51 50 50
Stock-based compensation expense 3,489 3,489 3,072
Deferred income taxes (223) (748) 4,195
Asset impairment charges 0 1,001 0
Loss on sale and disposition of property, plant and equipment 81 127 99
Increase in cash surrender value of life insurance policies over premiums paid (410) (452) (1,532)
Net changes in assets and liabilities (net of assets and liabilities acquired):      
Accounts receivable, net (10,574) (20,411) 5,116
Inventories (13,055) (36,466) 14,466
Accounts payable and accrued expenses 10,795 19,260 (639)
Other changes (809) 1,903 (1,338)
Total adjustments 7,080 (13,857) 38,902
Net cash provided by operating activities 36,627 27,163 58,207
Cash Flows From Investing Activities:      
Acquisition of businesses 0 (72,089) 0
Capital expenditures (11,788) (8,213) (19,149)
Increase in cash surrender value of life insurance policies (645) (581) (517)
Proceeds from sale of assets held for sale 0 5,011 0
Proceeds from sale of property, plant and equipment 4 107 4
Proceeds from surrender of life insurance policies 3 91 25
Net cash used for investing activities (12,426) (75,674) (19,637)
Cash Flows From Financing Activities:      
Proceeds from long-term debt 18,495 291 298
Principal payments on long-term debt (18,495) (291) (298)
Cash dividends paid (21,723) (21,761) (50,942)
Cash received from exercise of stock options 0 62 428
Payment of employee tax withholdings related to net share transactions (477) (425) (352)
Repurchases of common stock (3,151) (2,273) (1,836)
Net cash used for financing activities (25,351) (24,397) (52,702)
Net decrease in cash and cash equivalents (1,150) (72,908) (14,132)
Cash and cash equivalents at beginning of period 38,630 111,538 125,670
Cash and cash equivalents at end of period 37,480 38,630 111,538
Supplemental Disclosures of Cash Flow Information:      
Interest 11 0 0
us-gaap_NoncashInvestingAndFinancingItemsAbstract      
Purchases of property, plant and equipment in accounts payable 1,489 1,549 2,449
Restricted stock units and stock options surrendered for withholding taxes payable $ 477 $ 425 $ 352